Table 3.
Body fat percentage across trials (Mean ± SE). Non-BC (n=24)
| Trial One | Trial Two | Mean Difference ± SD | ICC | Effect Size | p-value | |
|---|---|---|---|---|---|---|
| DXA (BF%) | 30.6 ± 1.3 | 30.3 ± 1.4 | 0.2 ± 0.7 | 1.00 | 0.02 | 0.077 |
| ADP (BF%) | 28.8 ± 1.6 | 28.3 ± 1.6 | 0.5 ± 1.4 | 0.99 | 0.03 | 0.083 |
| Tanita (BF%) | 26.7 ± 1.5 | 27.1 ± 1.5 | −0.4 ± 1.1 | 0.99 | −0.03 | 0.122 |
| InBody 720 (BF%) | 26.1 ± 1.5 | 26.3 ± 1.5 | −0.3 ± 1.9 | 0.98 | −0.02 | 0.498 |
| InBody 230 (BF%) | 27.0 ± 1.4 | 26.8 ± 1.5 | 0.2 ± 1.4 | 0.99 | 0.02 | 0.523 |
No measurements were significantly different from menstruation (P > 0.05)